The right treatment depends on medical history, safety, FDA approval status, access, tolerance, side effects, muscle-preservation needs, metabolic risk, and long-term planning
In summary, in adults dealing with overweight or obesity (with at least one weight-related comorbidity), semaglutide treatment resulted in significant and sustained weight loss over the 104-week period compared to placebo
Tablets like Orlistat may benefit motivated individuals who have struggled to lose weight through diet and activity alone
Dietary Strategies to Reduce Semaglutide-Related Stomach Discomfort Small, frequent meals are the foundation of GLP-1 side-effect management
Supplement with basic cofactors for a week